3Tep liakov AT,Kuznetsova AV,Lukinov A V,et al.Effects ofa superselective beta l-adrenoblocker nebivolol on the course of coronary heart diease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting[J].Ter A rkh.2007.79(1):38-43.
6DiNapoli P,Taccardi AA,Bardotti A.Long term cardio-protective action of trimetazidine and potential effect on the inflammatory process in patients with ischemic dilated cardiomyopathy[J].Heart,2(05,92(2):161-165.
4Capomolla S, Febo O, Gnemmi M, et al. - blockade therapy in chronic heart failure diastolic function and mitral Regurgitation improvement by carvedilol[J]. Am Heart J, 2000, 139 (4) : 596.
5Foody J M, Farrell M H, Krumholz H M. Beta-blocker therapy in heart failure: scientific review[J]. JAMA, 2002, 287: 883.
6Hanna Szwed,Zygmunt Sadowski,Robert Pachocki,Ma?gorzata Dom?a?-Bocheńska,Krzysztof Szymczak,Zbigniew Szyd?owski,Andrzej Paradowski,Grzegorz Gajos,Grzegorz Ka?u?a,Irena Kulon,Anna W?tor-Brzezińska,Waldemar Elikowski,Maria Ku?niak. Proposed Antiischemic Effects of Trimetazidine in Coronary Diabetic Patients. A Substudy from TRIMPOL-1[J] 1999,Cardiovascular Drugs and Therapy(3):217～222
7Demaison L,Fantini E,Sentex E,et al.Trimetazidine: in vitro influenceon heart mitochondral function[].The American Journal of Cardiology.1995
8Kantor PF,Lucien A,Kozak R,et al.The antianginal drug trimetazidine shifts cardic energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase[].Circulation Research.2000
9Baetz D, Bernard M, Pinet C, et al. Different pathways of sodium entry in cardiac cells during ischemia and early reperfusion [ J ]. Mol Cell Biochem,2003,242 ( 1 - 2 ) : 115 - 120.
10Heinz loster,Thomas Keller. Effects of L - carnitine and etsacetyl and Propionylesters on ATP PCr levels of isolated rat hearts per- fused without fatty acids and invesiigatcd by means of 31P -NMR spectroscopy[ J ]. Mol Cell Biochem. 1999,200:93 - 102.
